Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Protein Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06513286
What this trial is testing

TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate

Who this might be right for
Chronic Hepatitis B
Michael Hoelscher 81
Large-scale testing (Phase 3)UnknownNCT00028886
What this trial is testing

Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Commissie Voor Klinisch Toegepast Onderzoek 450
Large-scale testing (Phase 3)Study completedNCT00002070
What this trial is testing

Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Schering-Plough
Testing effectiveness (Phase 2)Study completedNCT00229203
What this trial is testing

Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
PharmaMar 51
Testing effectiveness (Phase 2)Study completedNCT04099901
What this trial is testing

Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial

Who this might be right for
Multiple Myeloma
Radboud University Medical Center 88
Testing effectiveness (Phase 2)Study completedNCT00003077
What this trial is testing

Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Alliance for Clinical Trials in Oncology 63
Not applicableStudy completedNCT00659672
What this trial is testing

Effect of Whey Protein on Blood Pressure

Who this might be right for
High Blood Pressure
United States Department of Agriculture (USDA) 35
Not applicableStudy completedNCT01955395
What this trial is testing

Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
Dana-Farber Cancer Institute 93
Not applicableUnknownNCT03380039
What this trial is testing

Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma

Who this might be right for
Refractory or Relapsed Multiple Myeloma
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 6
Testing effectiveness (Phase 2)Study completedNCT04083534
What this trial is testing

First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM)

Who this might be right for
Relapsed Multiple MyelomaRefractory Multiple Myeloma
Regeneron Pharmaceuticals 43
Testing effectiveness (Phase 2)Looking for participantsNCT05469893
What this trial is testing

Immuno-PRISM (PRecision Intervention Smoldering Myeloma)

Who this might be right for
High-risk Smoldering Multiple MyelomaSmoldering Multiple MyelomaMultiple Myeloma
Irene Ghobrial, MD 52
Early research (Phase 1)Study completedNCT01748721
What this trial is testing

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+43 more
Morphotek 27
Testing effectiveness (Phase 2)Study completedNCT00709592
What this trial is testing

Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT

Who this might be right for
Non-Hodgkin's LymphomaLeukemiaMultiple Myeloma+5 more
Virginia Commonwealth University 42
Early research (Phase 1)Study completedNCT01567709
What this trial is testing

Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma

Who this might be right for
Adult B Acute Lymphoblastic LeukemiaAdult T Acute Lymphoblastic LeukemiaAnaplastic Large Cell Lymphoma+32 more
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT02193698
What this trial is testing

Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial

Who this might be right for
POEMS Syndrome
Chiba University 5
Testing effectiveness (Phase 2)UnknownNCT05147493
What this trial is testing

Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment

Who this might be right for
Multiple MyelomaRenal ImpairmentNeoplasms, Plasma Cell+5 more
Hellenic Society of Hematology 51
Large-scale testing (Phase 3)Study completedNCT02197221
What this trial is testing

Bortezomib-Melphalan Conditioning Regimen vs Melphalan for Frontline Transplant Eligible Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Hospital, Toulouse 300
Not applicableStudy completedNCT03212599
What this trial is testing

Disulfiram as a Modulator of Amyloid Precursor Protein-processing

Who this might be right for
Alcohol Addiction
Johannes Gutenberg University Mainz 17
Not applicableLooking for participantsNCT06028087
What this trial is testing

Real-World Mapping Antithrombotic Regimens in MM Patients on Treatment

Who this might be right for
Multiple MyelomaDiagnosis
Gruppo Italiano Malattie EMatologiche dell'Adulto 736
Not applicableStudy completedNCT00576563
What this trial is testing

Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer

Who this might be right for
Rectum Cancer
Maastricht Radiation Oncology 103
Next Page